|
|
|
|
||
Re: The Journey To Rewrite Human DNA Is About To Get Wild, Thanks To These CRISPR Stocks Yeah I will not argue with that. I don’t actually care what any analyst says. However clearly 2022 is going to be a pivotal year for crisper stocks. If anyone is invested only in SGMO for the genomic space, you may want to consider broadening the view. |
return to message board, top of board |